Literature DB >> 14777197

Pheochromocytoma and essential hypertensive vascular disease.

M GOLDENBERG, H ARANOW, A A SMITH, M FABER.   

Abstract

Entities:  

Keywords:  BLOOD PRESSURE, HIGH; TUMORS, PHEOCHROMOCYTOMA

Mesh：

Year:  1950        PMID： 14777197     DOI： 10.1001/archinte.1950.00230180028003

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  21 in total

1.  The biochemistry of mental disease.

Authors:  A HOFFER; H OSMOND
Journal:  Can Med Assoc J       Date:  1961-12-09       Impact factor: 8.262

2.  The treatment of severe hypertension.

Authors:  M L ROSENHEIM
Journal:  Br Med J       Date:  1954-11-20

3.  Phaeochromocytoma with fatal myocardial infarction in a man aged 22.

Authors:  W M PRIEST
Journal:  Br Med J       Date:  1952-10-18

4.  Endocrine factors in hypertension.

Authors:  G A PERERA
Journal:  Bull N Y Acad Med       Date:  1952-01

5.  Noradrenaline, adrenaline, and the human circulation.

Authors:  H J C SWAN
Journal:  Br Med J       Date:  1952-05-10

6.  The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man.

Authors:  A G BEARN; B BILLING; S SHERLOCK
Journal:  J Physiol       Date:  1951-12-28       Impact factor: 5.182

7.  Autoimmune hypertensive syndrome.

Authors:  David C Kem; Xichun Yu; Eugene Patterson; Shijun Huang; Stavros Stavrakis; Bela Szabo; Leann Olansky; Jon McCauley; Madeleine W Cunningham
Journal:  Hypertension       Date:  2007-10-08       Impact factor: 10.190

8.  ADAPTATION TO POSTURAL CHANGE IN PSYCHIATRIC PATIENTS.

Authors:  A G Mezey; P H Melville
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-05       Impact factor: 10.154

9.  Operations on the adrenal glands.

Authors:  W P LONGMIRE; W F BARKER
Journal:  Calif Med       Date:  1952-08

10.  The glycaemic response of rabbits to 1-adrenaline and 1-noradrenaline and the effect thereon of dimercaprol.

Authors:  J D P GRAHAM; D M JAMES
Journal:  J Physiol       Date:  1952-12       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.